DK1031575T3 - Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler - Google Patents

Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler

Info

Publication number
DK1031575T3
DK1031575T3 DK00301526T DK00301526T DK1031575T3 DK 1031575 T3 DK1031575 T3 DK 1031575T3 DK 00301526 T DK00301526 T DK 00301526T DK 00301526 T DK00301526 T DK 00301526T DK 1031575 T3 DK1031575 T3 DK 1031575T3
Authority
DK
Denmark
Prior art keywords
preparation
growth hormone
hormone secretion
inducers
secretion inducers
Prior art date
Application number
DK00301526T
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1031575T3 publication Critical patent/DK1031575T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
DK00301526T 1999-02-26 2000-02-25 Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler DK1031575T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26
EP00301526A EP1031575B1 (en) 1999-02-26 2000-02-25 Process for preparing growth hormone secretagogues

Publications (1)

Publication Number Publication Date
DK1031575T3 true DK1031575T3 (da) 2005-01-03

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00301526T DK1031575T3 (da) 1999-02-26 2000-02-25 Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler

Country Status (44)

Country Link
US (2) US6541634B2 (da)
EP (2) EP1449842A1 (da)
JP (3) JP3437813B2 (da)
KR (2) KR100372063B1 (da)
CN (3) CN1837205A (da)
AP (1) AP1221A (da)
AR (2) AR029617A1 (da)
AT (1) ATE277944T1 (da)
AU (1) AU764122B2 (da)
BG (1) BG104175A (da)
BR (2) BRPI0017522B8 (da)
CA (1) CA2299495C (da)
CO (1) CO5160252A1 (da)
DE (1) DE60014212T2 (da)
DK (1) DK1031575T3 (da)
DZ (1) DZ3018A1 (da)
EA (1) EA003218B1 (da)
EE (1) EE200000193A (da)
ES (1) ES2226712T3 (da)
GT (1) GT200000018A (da)
HK (1) HK1030219A1 (da)
HN (1) HN2000000021A (da)
HR (1) HRP20000103A2 (da)
HU (1) HUP0000907A3 (da)
ID (1) ID24861A (da)
IL (2) IL157103A (da)
IN (1) IN192352B (da)
IS (1) IS5380A (da)
MA (1) MA25072A1 (da)
NO (1) NO20000965L (da)
NZ (1) NZ503062A (da)
OA (1) OA11325A (da)
PA (1) PA8491201A1 (da)
PE (1) PE20001550A1 (da)
PL (1) PL338628A1 (da)
PT (1) PT1031575E (da)
SG (1) SG90096A1 (da)
SI (1) SI1031575T1 (da)
SK (1) SK284982B6 (da)
TN (1) TNSN00035A1 (da)
TR (1) TR200000536A2 (da)
TW (2) TWI286142B (da)
UA (1) UA70306C2 (da)
ZA (1) ZA200000888B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
WO2001091752A1 (en) 2000-05-30 2001-12-06 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
WO2014192294A1 (en) * 2013-05-28 2014-12-04 Raqualia Pharma Inc. Polymorph forms
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
PL322706A1 (en) 1993-11-09 1998-02-16 Merck & Co Inc Piperidines, pyrolidines and hexahydro-1h-azepins enhancing growth hormone liberation
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
NO20000965L (no) 2000-08-28
KR100372063B1 (ko) 2003-02-14
SK284982B6 (sk) 2006-03-02
EA200000172A2 (ru) 2000-08-28
EA200000172A3 (ru) 2000-10-30
IN192352B (da) 2004-04-10
BRPI0000967B8 (pt) 2021-12-07
HK1030219A1 (en) 2001-04-27
AP2000001754A0 (en) 2000-03-31
MA25072A1 (fr) 2000-10-01
BRPI0017522B1 (pt) 2013-09-24
JP4051314B2 (ja) 2008-02-20
BRPI0000967A (pt) 2001-09-11
EP1031575A1 (en) 2000-08-30
SG90096A1 (en) 2002-07-23
DE60014212D1 (de) 2004-11-04
US20030158414A1 (en) 2003-08-21
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
US6673929B2 (en) 2004-01-06
TWI286142B (en) 2007-09-01
BRPI0017522B8 (pt) 2021-05-25
ATE277944T1 (de) 2004-10-15
HU0000907D0 (en) 2000-04-28
PA8491201A1 (es) 2001-04-30
SK2302000A3 (en) 2000-11-07
BRPI0000967B1 (pt) 2012-06-12
TR200000536A2 (tr) 2000-09-21
JP2003327585A (ja) 2003-11-19
JP2000247974A (ja) 2000-09-12
US20020002283A1 (en) 2002-01-03
JP3437813B2 (ja) 2003-08-18
GT200000018A (es) 2001-08-16
TW200718702A (en) 2007-05-16
CA2299495C (en) 2010-06-15
HRP20000103A2 (en) 2001-04-30
JP2003261565A (ja) 2003-09-19
PE20001550A1 (es) 2001-01-11
IL157103A0 (en) 2004-02-08
KR20020065455A (ko) 2002-08-13
KR100361783B1 (ko) 2002-11-22
IL134599A0 (en) 2001-04-30
ZA200000888B (en) 2001-08-23
AR053722A2 (es) 2007-05-16
BRPI0017522A2 (da) 2009-12-22
SI1031575T1 (en) 2005-02-28
CN1515570A (zh) 2004-07-28
CO5160252A1 (es) 2002-05-30
BG104175A (bg) 2000-12-29
ES2226712T3 (es) 2005-04-01
CA2299495A1 (en) 2000-08-26
NO20000965D0 (no) 2000-02-25
OA11325A (en) 2003-10-27
EP1449842A1 (en) 2004-08-25
AU1947100A (en) 2000-08-31
IL157103A (en) 2007-07-24
CN1837205A (zh) 2006-09-27
AR029617A1 (es) 2003-07-10
CN1137891C (zh) 2004-02-11
IL134599A (en) 2006-12-10
KR20010006698A (ko) 2001-01-26
EA003218B1 (ru) 2003-02-27
TNSN00035A1 (fr) 2005-11-10
IS5380A (is) 2000-08-27
PL338628A1 (en) 2000-08-28
US6541634B2 (en) 2003-04-01
PT1031575E (pt) 2004-11-30
HUP0000907A3 (en) 2001-05-28
HUP0000907A2 (en) 2001-03-28
NZ503062A (en) 2001-07-27
ID24861A (id) 2000-08-31
DZ3018A1 (fr) 2004-03-20
AP1221A (en) 2003-11-03
CN1270960A (zh) 2000-10-25
AU764122B2 (en) 2003-08-07
HN2000000021A (es) 2001-02-02
UA70306C2 (en) 2004-10-15
DE60014212T2 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
DE69837264D1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
IS5276A (is) Tartrat salt af setnu dípeptíði sem vaxtarhormónsseytir
ATE362472T1 (de) Wachstumhormonsekretionsförderer
DK1044969T3 (da) Fremgangsmåde og mellemprodukter til fremstilling af anti-cancer forbindelser
DK1150966T3 (da) Fremgangsmåde til fremstilling af 5-cyanophthalid
EE200200183A (et) Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
DK1140886T3 (da) Fremgangsmåde til fremstilling af 5-cyanophtalid
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DE60038118D1 (de) Formulierungen von wachstumshormonen
DK1114023T3 (da) Fremgangsmåde til fremstilling af carboxylsyrer
ATE375996T1 (de) Sekretionsfordermittel fur wachtumshormon
DK1131083T3 (da) Anvendelse af væksthormonfrigørende forbindelser og antagonister deraf til behandling af tumorer
DK1031575T3 (da) Fremgangsmåde til fremstilling af væksthormonsekretionsfremkaldende midler
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
ATE339438T1 (de) Substanziell kristalline form von melagatran
PT1228056E (pt) Metodo de preparacao de citaloprame
DK1159296T3 (da) Fremgangsmåde til fremstilling af cyclo-(Asp-DPhe-NMeVal-Arg-Gly)
DK1294694T3 (da) Fremgangsmåde til fremstilling af quinolinderivater
DK1177165T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter
DK1399577T3 (da) Fremgangsmåde til fremstilling af L-aminosyrer
DK1238094T3 (da) Fremgangsmåde til fremstilling af optisk aktive cyanhyhydriner under anvendelse af R-oxynitrilase
DK1226125T3 (da) Fremgangsmåde til fremstilling af mavesårsmidler
DK1114174T3 (da) Fremgangsmåde til fremstilling af polycarboxylsyrer